Redox regulation of circadian molecular clock in chronic airway diseases

IK Sundar, MT Sellix, I Rahman - Free Radical Biology and Medicine, 2018 - Elsevier
IK Sundar, MT Sellix, I Rahman
Free Radical Biology and Medicine, 2018Elsevier
At the cellular level, circadian timing is maintained by the molecular clock, a family of
interacting clock gene transcription factors, nuclear receptors and kinases called clock
genes. Daily rhythms in pulmonary function are dictated by the circadian timing system,
including rhythmic susceptibility to the harmful effects of airborne pollutants, exacerbations
in patients with chronic airway disease and the immune-inflammatory response to infection.
Further, evidence strongly suggests that the circadian molecular clock has a robust …
Abstract
At the cellular level, circadian timing is maintained by the molecular clock, a family of interacting clock gene transcription factors, nuclear receptors and kinases called clock genes. Daily rhythms in pulmonary function are dictated by the circadian timing system, including rhythmic susceptibility to the harmful effects of airborne pollutants, exacerbations in patients with chronic airway disease and the immune-inflammatory response to infection. Further, evidence strongly suggests that the circadian molecular clock has a robust reciprocal interaction with redox signaling and plays a considerable role in the response to oxidative/carbonyl stress. Disruption of the circadian timing system, particularly in airway cells, impairs pulmonary rhythms and lung function, enhances oxidative stress due to airway inhaled pollutants like cigarette smoke and airborne particulate matter and leads to enhanced inflammosenescence, inflammasome activation, DNA damage and fibrosis. Herein, we briefly review recent evidence supporting the role of the lung molecular clock and redox signaling in regulating inflammation, oxidative stress, and DNA damage responses in lung diseases and their exacerbations. We further describe the potential for clock genes as novel biomarkers and therapeutic targets for the treatment of chronic lung diseases.
Elsevier